Background

I am a Consultant Psychiatrist currently working in Youth North Team, supporting young people aged 12-25 in the community. I also work clinically in functional gut disorders. I have a sub-specialisation in structured psychotherapies, and provides gut-focused CBT to clients with functional gut disorders.

I also hold academic appointments as a Senior Research Fellow at Deakin University, a clinical academic at Barwon Health and Psychiatric Clinical Lead at the Food & Mood Centre.

I completed my training in psychiatry at the Austin Hospital, and went on to pursue a clinical academic career, completing my PhD in 2024.

For my PhD, I developed and led a pilot randomised controlled trial investigating the use of Faecal Microbiota Transplants (FMT) for Major Depressive Disorder.  The study was the first RCT of FMT for a mental health disorder, and my work was recently featured in The Australian Story (https://www.abc.net.au/news/2025-07-28/gut-instinct-jane-dudley/105583270) .


Research Focus

My current research is primarily focused on the gut-brain-axis, and lifestyle psychiatry translation. I am passionate about translating the robust evidence base for lifestyle psychiatry into clinical practice, and am currently leading a number of projects in this theme.  I also continue to be actively involved in Faecal Microbiota Transplants (FMT) research and am currently a Chief Investigator on two MRFF-funded studies of FMT. The first is investigating the use of FMT for the psychological sequelae of long COVID, and the second in chronic pelvic pain.


Awards & Achievements

  • My novel work into FMT for mental health conditions has attracted significant media interest. I have been interviewed on The Australian Story, print media (New Scientist, The New York Times, ABC News Online) and radio (Triple R, ABC Radio).  My work was also featured in Professor Gordon Parker’s book, A Gut Mood Solution.
  • 2025  IMPACT Award for Outstanding PhD Completion in 2024, IMPACT, Deakin University
  • 2025 Chief Investigator: MRFF Novel Treatments and Management Strategies for Chronic Pain, $800,000 awarded to support Faecal microbiota Transplantation for chronic pelvic pain: The GRACE Study
  • 2024 IMPACT Award for Excellence in Clinician-Led Research in 2023-2024, IMPACT, Deakin University
  • 2024 Chief investigator: Medical Research Future Fund (MRFF), $996,924 awarded to support Pathways of Influence through the Gut Microbiome in Post-Acute COVID-19 Sequelae: The GLOW Study, Barwon Health and Deakin University
  • 2019-2024 IMPACT PhD Scholarship, Deakin University awarded for Part-time PhD stipend
  • 2020 IMPACT Seed Funding, Deakin University, $18,745 awarded in funding to support employment of Research Assistant for the Moving Moods Pilot Study
  • 2019 IMPACT Seed Funding, Deakin University, $7,820 awarded in funding to support intestinal microbiota testing for the Moving Moods Pilot Study
  • 2008 Scholarship awarded to attend East Asia Medical Students’ Conference
  • 2006 Chris Salagy Award presented by the Dean of Medicine for excellence in the Community Partnerships Program

About me...

Signature dish:

 

Whatever means I can, to get the kids to try new foods and eat their vegies!
Coffee order:

 

Boring I suppose, but a cappuccino is my regular order

Feature Publications

  • “A poo dose a day may keep bipolar away. When it comes to mental health, what else could poo do?”, The Conversation, Authors: Jessica Green and Gordon Parker, https://theconversation.com/a-poo-dose-a-day-may-keep-bipolar-away-when-it-comes-to-mental-health-what-else-could-poo-do-177748
  • Green J, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S. Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar;226(3):171-183. doi: 10.1192/bjp.2024.121. Epub 2024 Dec 11. PMID: 39658347.
  • Green J, McGuinness A, Berk M, Castle D, Athan E, Hair C, Strandwitz P, Loughman A, Nierenberg A, Cryan J, Mohebbi M, Jacka F. Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial. Pilot Feasibility Studies. Jan 2023
  • Green J, Berk M, Mohebbi M, Loughman A, McGuinness A, Castle D, Chatterton ML, Perez J, Strandwitz P, Athan E, Hair C, Nierenberg A, Cryan J, Jacka F. Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial. The Canadian Journal of Psychiatry. Jan 2023
  • McGuinness A, Davis J, Dawson S, Loughman A, Collier F, O’Hely M, Simpson C, Green J, Marx W, Hair C, Guest G, Mohebbi M, Berk M, Stupart D, Watters D, Jacka F. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Molecular Psychiatry. Feb 2022

How you can help

Participate in a Clinical Trial

To find out about Clinical Trials currently underway at Barwon Health, click here. To learn more about the Adrian Costa Clinical Trials Centre, click here.

Donate

Research requires ongoing investment and there are several ways to support our work. You can make a donation today and contribute to an item on our research group’s wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support will deliver an immediate impact to this important work. To donate now or for more information, please contact the Barwon Health Foundation.